58
Participants
Start Date
July 31, 2015
Primary Completion Date
September 30, 2019
Study Completion Date
September 30, 2019
HD-tDCS (Soterix Medical, Active)
Subject will be given individualized dose (number of electrodes and electrode placement) through High-Definition electrodes to target fMRI determined targets.
HD-tDCS (Soterix Medical, Sham)
Subject will be given individualized dose (number of electrodes and electrode placement) through High-Definition electrodes to target fMRI determined targets.
Georgetown University Medical Center (Peter Turkeltaub, MD, Ph.D.), Washington D.C.
University of North Carolina School of Medicine (Adam Jacks, Ph.D.), Chapel Hill
Lead Sponsor
Collaborators (1)
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Georgetown University
OTHER
University of North Carolina, Chapel Hill
OTHER
The City College of New York
OTHER
Medstar Health Research Institute
OTHER
University of South Carolina
OTHER
Soterix Medical
INDUSTRY